Overview

Trial to Determine Efficacy of Fexinidazole in Visceral Leihmaniasis Patients in Sudan

Status:
Terminated
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This study is designed to determine the efficacy of Fexinidazole as an oral treatment in Visceral Leishmanisasis sudanese adults patients. The results of this proof of concept study will allow to make a decision on whether to proceed with clinical development of Fexinidazole for visceral leishmaniasis.
Phase:
Phase 2
Details
Lead Sponsor:
Drugs for Neglected Diseases